✦ LIBER ✦

Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma

✍ Scribed by Gilda Tonziello, Marintonietta Pisaturo, Antonello Sica…

Book ID: 120739380
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 200 KB
Volume: 41
Category: Article
ISSN: 0300-8126
DOI: 10.1007/s15010-012-0305-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamivudine to prevent hepati

Efficacy of lamivudine to prevent hepatitis reactivation in HBV infected patients treated for non-Hodgkin lymphoma

✍ Marcello Persico; Fedele De Marino; Eliana Persico; Giovanni Di Giacomo; Bruno P 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

High prevalence of occult hepatitis B vi

High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma

✍ Ming-Huang Chen; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Jin-Hwang Liu; Jyh-Pyng Gau; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 121 KB

Effect of Antiviral Prophylaxis Strategy

Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study

✍ Fan Yang, Huan-Ling Zhu, Chuan He… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 356 KB

Possible efficacy of lamivudine treatmen

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

✍ Y. Tsutsumi; J. Tanaka; T. Kawamura; T. Miura; H. Kanamori; S. Obara; M. Asaka; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 106 KB

A revisit of prophylactic lamivudine for

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

✍ Chiun Hsu; Chao A. Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patients who undergo chemotherapy, but the optimal treatment protocol remains undetermined. In this study, HBV carriers with newly diagnosed non-Hodgkin's lymphoma (NHL) who underwent chemotherapy were ran

A possible role for lamivudine as prophy

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma

✍ Endo, T; Sakai, T; Fujimoto, K; Yamamoto, S; Takashima, H; Haseyama, Y; Nishio, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB